According to Agenus
's latest financial reports the company has -$0.15 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $-0.15 B | 170.27% |
2022-12-31 | $-54.91 M | -214.6% |
2021-12-31 | $47.9 M | -122.65% |
2020-12-31 | $-0.22 B | -8.58% |
2019-12-31 | $-0.24 B | 32.54% |
2018-12-31 | $-0.18 B | 130.22% |
2017-12-31 | $-75.82 M | 93.77% |
2016-12-31 | $-39.13 M | -155.32% |
2015-12-31 | $70.72 M | 207.27% |
2014-12-31 | $23.01 M | -613.72% |
2013-12-31 | $-4.49 M | -74.54% |
2012-12-31 | $-17.61 M | -15.51% |
2011-12-31 | $-20.84 M | 41.64% |
2010-12-31 | $-14.71 M | -13.36% |
2009-12-31 | $-16.98 M | -16.5% |
2008-12-31 | $-20.34 M | -56.8% |
2007-12-31 | $-47.07 M | 170.56% |
2006-12-31 | $-17.4 M | -154.53% |
2005-12-31 | $31.89 M | -70.03% |
2004-12-31 | $0.10 B | 1.14% |
2003-12-31 | $0.10 B | 35.35% |
2002-12-31 | $77.75 M | 2.41% |
2001-12-31 | $75.92 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | -46,449.29% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | -25,463.59% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $29.48 B | -19,971.01% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $16.28 B | -11,077.07% | ๐ฌ๐ง UK |
Celldex Therapeutics CLDX | $0.42 B | -389.23% | ๐บ๐ธ USA |